Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carvedilol overdose

P Hantson1, J Y Lambermont, G Simoens

  • 1Department of Intensive Care, Cliniques Universitaires St-Luc, Brussels, Belgium. hantson@rean.ucl.ac.be

Acta Cardiologica
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Carvedilol, a non-selective beta-blocker with alpha-1 blockade, effectively treats hypertension and angina. It is also being investigated for congestive heart failure treatment.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carboxyhemoglobin half-life toxicokinetic profiles during and after normobaric oxygen therapy: On a swine model.

Toxicology reports·2024
Same author

Long-term intensive care unit outbreak of carbapenemase-producing organisms associated with contaminated sink drains.

The Journal of hospital infection·2024
Same author

Extreme Rhabdomyolysis, Acute Renal Failure, and Protracted Ileus in a Case of Legionella Pneumonia.

Case reports in critical care·2019
Same author

Status epilepticus and white matter ischemia complicating dural arteriovenous fistula.

Acta neurologica Belgica·2018
Same author

Neuroinvasive Infection from O117:K52:H-<i>Escherichia coli</i> following Acute Pyelonephritis.

Case reports in infectious diseases·2018
Same author

Acute Bacterial Meningitis and Systemic Abscesses due to <i>Streptococcus dysgalactiae</i> subsp. <i>equisimilis</i> Infection.

Case reports in infectious diseases·2017
Same journal

Dialysis-related spontaneous anterior mediastinal hemorrhage.

Acta cardiologica·2026
Same journal

From the arrhythmia to the substrate: the role of atrial cardiomyopathy in atrial fibrillation management.

Acta cardiologica·2026
Same journal

Presence of anti-cardiac troponin I antibodies (cTnIAb) and their role in the left ventricular remodelling, in patients with acute myocardial infarction.

Acta cardiologica·2026
Same journal

Guideline-recommended medical therapy and clinical outcomes in cancer patients with de Novo heart failure.

Acta cardiologica·2026
Same journal

Association between red cell distribution width and all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Acta cardiologica·2026
Same journal

The ventricular assist device outflow cannula anastomosis to the descending aorta in a patient with porcelain aorta.

Acta cardiologica·2026
See all related articles

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Carvedilol is a non-selective beta-adrenoceptor antagonist.
  • It exhibits peripheral vasodilation through alpha-1 adrenergic blockade.

Observation:

  • Carvedilol has demonstrated efficacy in managing mild-to-moderate hypertension.
  • The drug is also effective for angina treatment.

Findings:

  • Carvedilol's dual mechanism of action contributes to its therapeutic effects.
  • Clinical investigations are exploring its utility in congestive heart failure.

Implications:

  • Carvedilol represents a significant therapeutic option for cardiovascular conditions.
  • Further research may expand its clinical applications in heart failure management.